Skip to main content

Startup aiming for FDA clearance to open 'floodgates' on heart surgery simulation software

“As soon as we get FDA clearance, that opens the floodgates,” co-founder and CEO Teri Sirset said. "In our minds, we think this is a unicorn. ... 2023 is going to be a telltale year for us."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.